203 related articles for article (PubMed ID: 35411251)
1. Bombesin-drug conjugates in targeted therapy for small cell lung cancer.
Zhang Y; Holland E; Dinh A; Au D; Sun L
Am J Cancer Res; 2022; 12(3):927-937. PubMed ID: 35411251
[TBL] [Abstract][Full Text] [Related]
2. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC).
Deneka AY; Boumber Y; Beck T; Golemis EA
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31484422
[TBL] [Abstract][Full Text] [Related]
4. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
5. The release of bombesin-like peptides from small cell lung cancer cells.
Moody TW; Korman LY
Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597
[TBL] [Abstract][Full Text] [Related]
6. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.
Schally AV; Nagy A
Eur J Endocrinol; 1999 Jul; 141(1):1-14. PubMed ID: 10407215
[TBL] [Abstract][Full Text] [Related]
7. Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Jett JR; Schild SE; Kesler KA; Kalemkerian GP
Chest; 2013 May; 143(5 Suppl):e400S-e419S. PubMed ID: 23649448
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy for the treatment of a post-chemotherapy remnant lung mass in extensive-stage small-cell lung cancer: A case report.
Yeo SG; Kim MJ
Exp Ther Med; 2016 Aug; 12(2):1185-1188. PubMed ID: 27446341
[TBL] [Abstract][Full Text] [Related]
9. Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy.
Sun A; Durocher-Allen LD; Ellis PM; Ung YC; Goffin JR; Ramchandar K; Darling G
Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):658-666. PubMed ID: 30007803
[TBL] [Abstract][Full Text] [Related]
10. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
11. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
Cuttitta F; Carney DN; Mulshine J; Moody TW; Fedorko J; Fischler A; Minna JD
Nature; 1985 Aug 29-Sep 4; 316(6031):823-6. PubMed ID: 2993906
[TBL] [Abstract][Full Text] [Related]
12. Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Lange W; Mertelsmann R
Ann Oncol; 1999 May; 10(5):561-7. PubMed ID: 10416006
[TBL] [Abstract][Full Text] [Related]
13. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
14. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
15. Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer.
Scagliotti GV; Piani M; Gatti E; Gozzelino F; Albera C; Pozzi E
Eur Respir J; 1989 Sep; 2(8):746-50. PubMed ID: 2553476
[TBL] [Abstract][Full Text] [Related]
16. Advances in pharmacotherapy of small cell lung cancer.
Kalemkerian GP
Expert Opin Pharmacother; 2014 Nov; 15(16):2385-96. PubMed ID: 25255939
[TBL] [Abstract][Full Text] [Related]
17. Small cell lung cancer: defining a role for emerging platinum drugs.
Schiller JH
Oncology; 2002; 63(2):105-14. PubMed ID: 12239444
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cells.
Takuwa N; Takuwa Y; Ohue Y; Mukai H; Endoh K; Yamashita K; Kumada M; Munekata E
Cancer Res; 1990 Jan; 50(2):240-4. PubMed ID: 1688510
[TBL] [Abstract][Full Text] [Related]
19. Current Diagnosis and Management of Small-Cell Lung Cancer.
Wang S; Zimmermann S; Parikh K; Mansfield AS; Adjei AA
Mayo Clin Proc; 2019 Aug; 94(8):1599-1622. PubMed ID: 31378235
[TBL] [Abstract][Full Text] [Related]
20. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
